ADC Historical Balance Sheet

ADCT Stock

USD 1.58 0.04 2.47%

Trend analysis of ADC Therapeutics SA balance sheet accounts such as Other Current Liab of 33.5 M, Total Current Liabilities of 48.6 M or Property Plant And Equipment Net of 19.5 M provides information on ADC Therapeutics' total assets, liabilities, and equity, which is the actual value of ADC Therapeutics to its prevalent stockholders. By breaking down trends over time using ADC Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining ADC Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ADC Therapeutics is a good buy for the upcoming year.

ADC Therapeutics Inventory

19.53 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADC Therapeutics SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About ADC Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ADC Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. ADC Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ADC Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ADC currently owns. An asset can also be divided into two categories, current and non-current.

ADC Therapeutics Balance Sheet Chart

At this time, ADC Therapeutics' Property Plant And Equipment Gross is comparatively stable compared to the past year.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of ADC Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ADC Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ADC Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ADC Therapeutics SA are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from ADC Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ADC Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADC Therapeutics SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At this time, ADC Therapeutics' Property Plant And Equipment Gross is comparatively stable compared to the past year.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	68.5M	50.6M	58.2M	33.5M
Total Assets	529.2M	354.8M	408.0M	375.5M

Other Current Liab Total Assets

ADC Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Liab	Net Tangible Assets	Other Assets	Common Stock Total Equity	Common Stock Shares Outstanding
Total Assets		0.86	0.87	-0.11	0.66	0.52	-0.74	-0.79	0.73	0.98	0.93	0.83	0.98	0.68	0.76	0.88	0.85	0.78	1.0	0.83	0.83	0.84	-0.34	0.69	0.83	0.71
Other Current Liab	0.86		1.0	-0.5	0.83	0.71	-0.33	-0.94	0.91	0.76	0.76	0.99	0.76	0.86	0.88	0.98	0.96	0.9	0.86	0.96	0.94	0.56	-0.7	0.63	0.88	0.91
Total Current Liabilities	0.87	1.0		-0.46	0.81	0.72	-0.36	-0.92	0.91	0.78	0.79	0.99	0.78	0.88	0.87	0.98	0.95	0.89	0.88	0.95	0.91	0.56	-0.69	0.68	0.86	0.88
Total Stockholder Equity	-0.11	-0.5	-0.46		-0.79	-0.77	-0.52	0.65	-0.62	-0.04	0.04	-0.53	-0.04	-0.39	-0.72	-0.44	-0.49	-0.7	-0.15	-0.5	-0.46	0.11	0.8	0.08	-0.5	-0.69
Property Plant And Equipment Net	0.66	0.83	0.81	-0.79		0.8	-0.08	-0.95	0.85	0.61	0.5	0.85	0.61	0.58	0.97	0.79	0.86	0.97	0.68	0.86	0.85	0.46	-0.8	0.25	0.91	0.93
Current Deferred Revenue	0.52	0.71	0.72	-0.77	0.8		0.07	-0.73	0.78	0.43	0.37	0.71	0.43	0.69	0.85	0.68	0.61	0.85	0.54	0.63	0.53	0.1	-0.74	0.41	0.57	0.76
Net Debt	-0.74	-0.33	-0.36	-0.52	-0.08	0.07		0.25	-0.23	-0.83	-0.72	-0.29	-0.83	-0.15	-0.19	-0.39	-0.39	-0.21	-0.73	-0.35	-0.38	-0.83	-0.29	-0.47	-0.37	-0.14
Retained Earnings	-0.79	-0.94	-0.92	0.65	-0.95	-0.73	0.25		-0.91	-0.73	-0.65	-0.94	-0.73	-0.7	-0.96	-0.9	-0.96	-0.96	-0.8	-0.95	-0.94	-0.58	0.76	-0.4	-0.95	-0.92
Accounts Payable	0.73	0.91	0.91	-0.62	0.85	0.78	-0.23	-0.91		0.68	0.52	0.92	0.68	0.68	0.88	0.85	0.92	0.88	0.76	0.93	0.84	0.42	-0.74	0.41	0.78	0.9
Cash	0.98	0.76	0.78	-0.04	0.61	0.43	-0.83	-0.73	0.68		0.86	0.73	1.0	0.52	0.71	0.79	0.8	0.72	0.98	0.77	0.78	0.9	-0.21	0.56	0.78	0.64
Non Current Assets Total	0.93	0.76	0.79	0.04	0.5	0.37	-0.72	-0.65	0.52	0.86		0.73	0.86	0.7	0.61	0.79	0.7	0.63	0.89	0.7	0.73	0.79	-0.3	0.84	0.74	0.54
Non Currrent Assets Other	0.83	0.99	0.99	-0.53	0.85	0.71	-0.29	-0.94	0.92	0.73	0.73		0.73	0.84	0.88	0.96	0.96	0.9	0.83	0.98	0.94	0.52	-0.75	0.61	0.89	0.92
Cash And Short Term Investments	0.98	0.76	0.78	-0.04	0.61	0.43	-0.83	-0.73	0.68	1.0	0.86	0.73		0.52	0.71	0.79	0.8	0.72	0.98	0.77	0.78	0.9	-0.21	0.56	0.78	0.64
Net Receivables	0.68	0.86	0.88	-0.39	0.58	0.69	-0.15	-0.7	0.68	0.52	0.7	0.84	0.52		0.68	0.87	0.7	0.71	0.67	0.71	0.68	0.27	-0.61	0.79	0.62	0.69
Non Current Liabilities Total	0.76	0.88	0.87	-0.72	0.97	0.85	-0.19	-0.96	0.88	0.71	0.61	0.88	0.71	0.68		0.87	0.88	1.0	0.78	0.87	0.85	0.53	-0.72	0.39	0.9	0.92
Other Current Assets	0.88	0.98	0.98	-0.44	0.79	0.68	-0.39	-0.9	0.85	0.79	0.79	0.96	0.79	0.87	0.87		0.93	0.88	0.89	0.92	0.92	0.62	-0.58	0.66	0.87	0.89
Other Stockholder Equity	0.85	0.96	0.95	-0.49	0.86	0.61	-0.39	-0.96	0.92	0.8	0.7	0.96	0.8	0.7	0.88	0.93		0.89	0.87	0.99	0.97	0.66	-0.64	0.45	0.93	0.92
Total Liab	0.78	0.9	0.89	-0.7	0.97	0.85	-0.21	-0.96	0.88	0.72	0.63	0.9	0.72	0.71	1.0	0.88	0.89		0.8	0.88	0.86	0.54	-0.73	0.42	0.91	0.92
Total Current Assets	1.0	0.86	0.88	-0.15	0.68	0.54	-0.73	-0.8	0.76	0.98	0.89	0.83	0.98	0.67	0.78	0.89	0.87	0.8		0.84	0.84	0.84	-0.34	0.65	0.83	0.73
Intangible Assets	0.83	0.96	0.95	-0.5	0.86	0.63	-0.35	-0.95	0.93	0.77	0.7	0.98	0.77	0.71	0.87	0.92	0.99	0.88	0.84		0.97	0.6	-0.72	0.5	0.92	0.92
Common Stock	0.83	0.94	0.91	-0.46	0.85	0.53	-0.38	-0.94	0.84	0.78	0.73	0.94	0.78	0.68	0.85	0.92	0.97	0.86	0.84	0.97		0.69	-0.62	0.47	0.96	0.92
Other Liab	0.84	0.56	0.56	0.11	0.46	0.1	-0.83	-0.58	0.42	0.9	0.79	0.52	0.9	0.27	0.53	0.62	0.66	0.54	0.84	0.6	0.69		0.0	0.36	0.72	0.46
Net Tangible Assets	-0.34	-0.7	-0.69	0.8	-0.8	-0.74	-0.29	0.76	-0.74	-0.21	-0.3	-0.75	-0.21	-0.61	-0.72	-0.58	-0.64	-0.73	-0.34	-0.72	-0.62	0.0		-0.31	-0.64	-0.72
Other Assets	0.69	0.63	0.68	0.08	0.25	0.41	-0.47	-0.4	0.41	0.56	0.84	0.61	0.56	0.79	0.39	0.66	0.45	0.42	0.65	0.5	0.47	0.36	-0.31		0.41	0.37
Common Stock Total Equity	0.83	0.88	0.86	-0.5	0.91	0.57	-0.37	-0.95	0.78	0.78	0.74	0.89	0.78	0.62	0.9	0.87	0.93	0.91	0.83	0.92	0.96	0.72	-0.64	0.41		0.89
Common Stock Shares Outstanding	0.71	0.91	0.88	-0.69	0.93	0.76	-0.14	-0.92	0.9	0.64	0.54	0.92	0.64	0.69	0.92	0.89	0.92	0.92	0.73	0.92	0.92	0.46	-0.72	0.37	0.89

Click cells to compare fundamentals

ADC Therapeutics Account Relationship Matchups

ADC Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	513.7M	618.0M	529.2M	354.8M	408.0M	375.5M
Other Current Liab	29.4M	49.5M	68.5M	50.6M	58.2M	33.5M
Total Current Liabilities	40.4M	73.9M	99.0M	67.7M	77.8M	48.6M
Total Stockholder Equity	335.5M	166.1M	88.7M	(148.2M)	(133.4M)	(126.8M)
Property Plant And Equipment Net	4.8M	11.2M	10.0M	16.1M	18.6M	19.5M
Current Deferred Revenue	1.8M	834K	149K	3.8M	4.3M	4.5M
Net Debt	(397.3M)	(364.8M)	(209.1M)	(154.2M)	(138.8M)	(145.7M)
Retained Earnings	(694.9M)	(924.9M)	(1.1B)	(1.3B)	(1.2B)	(1.1B)
Accounts Payable	5.3M	12.1M	12.4M	15.6M	17.9M	9.0M
Cash	439.2M	466.5M	326.4M	278.6M	320.4M	298.6M
Non Current Assets Total	63.2M	92.8M	83.2M	18.5M	21.3M	40.1M
Non Currrent Assets Other	397K	693K	903K	711K	817.7K	509.0K
Cash And Short Term Investments	439.2M	466.5M	326.4M	278.6M	320.4M	298.6M
Net Receivables	3.1M	30.2M	73.0M	25.2M	29.0M	19.8M
Liabilities And Stockholders Equity	513.7M	618.0M	529.2M	354.8M	408.0M	375.5M
Non Current Liabilities Total	137.8M	377.9M	341.5M	435.4M	500.7M	525.7M
Other Current Assets	11.3M	17.3M	23.5M	16.3M	18.8M	9.9M
Other Stockholder Equity	981.1M	981.7M	1.2B	1.2B	1.4B	827.5M
Total Liab	178.2M	451.9M	440.4M	503.0M	578.5M	607.4M
Total Current Assets	450.5M	525.2M	446.0M	336.3M	386.7M	335.4M
Accumulated Other Comprehensive Income	43.0M	102.8M	155.3M	(93K)	(107.0K)	(101.6K)
Intangible Assets	8.4M	10.2M	13.6M	14.4M	16.5M	9.7M
Common Stock	4.4M	6.3M	6.4M	7.3M	8.4M	4.5M
Other Liab	2.7M	100.5M	65.1M	25.3M	29.1M	36.3M
Net Tangible Assets	102.7M	325.3M	153.1M	75.3M	67.8M	64.4M
Other Assets	397K	27.4M	28.6M	1.0	1.15	1.09
Common Stock Shares Outstanding	65.4M	76.7M	78.2M	81.7M	94.0M	75.7M
Inventory	6.5M	11.1M	18.6M	16.2M	18.6M	19.5M
Net Invested Capital	447.1M	297.8M	198.4M	(35.5M)	(32.0M)	(30.4M)
Property Plant And Equipment Gross	4.8M	11.2M	15.9M	20.4M	23.5M	24.6M
Net Working Capital	410.0M	451.2M	347.1M	268.6M	308.9M	305.5M
Property Plant Equipment	6.3M	4.8M	11.2M	10.0M	11.5M	6.4M
Capital Stock	4.4M	6.3M	6.4M	7.3M	8.4M	5.9M
Short Long Term Debt Total	41.9M	101.8M	117.4M	124.4M	143.0M	85.9M
Capital Lease Obligations	3.5M	8.0M	7.7M	11.6M	13.4M	7.9M
Short Term Debt	5.6M	8.6M	1.1M	1.5M	1.3M	1.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for ADC Stock Analysis

When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ADC Historical Balance Sheet

ADC Therapeutics Inventory

19.53 Million

About ADC Balance Sheet Analysis

ADC Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

ADC Therapeutics balance sheet Correlations

ADC Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ADC Therapeutics balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for ADC Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Non Currrent Assets Other	+ 0.99	Other Current Liab
Non Currrent Assets Other	+ 0.99	Total Current Liabilities

Total Liab	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.96	Retained Earnings
Non Current Liabilities Total	- 0.96	Retained Earnings
Common Stock Total Equity	- 0.95	Retained Earnings
Intangible Assets	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Property Plant And Equipment Net